证券代码：000813 证券简称：德展健康 公告编号：2025-044 德展大健康股份有限公司 关于持股 5%以上股东所持公司股份拍卖过户完成 暨新增持股 5%以上股东的公告 股东上海岳野股权投资管理合伙企业（有限合伙）保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 一、第五次拍卖相关情况 德展大健康股份有限公司（以下简称"公司"、"上市公司"）于近日收到 公司持股 5%以上股东上海岳野股权投资管理合伙企业（有限合伙）（以下简称 "上海岳野"）清算组出具的《股票拍卖过户告知函》，获悉其在第五次拍卖股 份中被竞拍成功的公司 124,600,010 股股份已于近日办理完成过户登记手续，上 述股份占公司目前总股本比例为 5.76%，占剔除公司回购专用账户股份数量后的 公司总股本比例为 5.87%1。本次拍卖股份过户完成后，竞买人陈致文龙持有公司 109,500,000 股股份（占公司目前总股本比例为 5.06%，占剔除公司回购专用账 户股份数量后的公司总股本比例为 5.16%），成为持有公司 5%以上股份的股东。 ...

德展大健康股份有限公司 简式权益变动报告书 上市公司名称：德展大健康股份有限公司 股票上市地点：深圳证券交易所 股票简称：德展健康 股票代码：000813 信息披露义务人：陈致文龙 住所：北京市朝阳区工体西路 通讯地址：北京市朝阳区工体西路 股份变动性质：股份增加（公开拍卖竞得股份） 签署日期：2025年6月20日 1 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》《上市公司收购管理办法》 《深圳证券交易所股票上市规则》《公开发行证券的公司信息披露内容与格式准则 第15号——权益变动报告书》等相关的法律、法规和规范性文件编制本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反 信息披露义务人章程或内部规则中的任何条款，或与之相冲突。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《深圳证券交易所 股票上市规则》《公开发行证券的公司信息披露内容与格式准则第15号——权益变动报 告书》的规定，本报告书已全面披露了信息披露义务人在德展大健康股份有限公司中拥 有权益的股份变动情况。 四、截至本报告书签署之日，除本报告书披露的信息外，上述信息披露义务人 没有通过 ...

Core Viewpoint - The announcement indicates a significant change in shareholding structure for Dezhan Health, with a major shareholder transferring a substantial number of shares to a new investor, which may impact the company's governance and future strategies [1] Shareholding Changes - Shanghai Yueye, a shareholder holding over 5% of shares, has transferred 125 million shares, representing 5.76% of the company's total share capital and 5.87% when excluding shares in the repurchase account [1] - The new shareholder, Chen Zhiwenlong, now holds 109 million shares, accounting for 5.06% of the total share capital and 5.16% when excluding shares in the repurchase account [1]

Core Points - The announcement details the sixth public auction of shares held by a major shareholder, Shanghai Yueye, involving 199,199,990 shares of Dezhang Health, which represents 9.20% of the company's total share capital [1][2][5] - The auction was conducted on the JD Judicial Auction platform, and the results indicated that 102,045,343 shares were successfully auctioned, accounting for 4.71% of the company's total share capital [3][5] - The auction does not affect the control of the company, as Shanghai Yueye is not the controlling shareholder, and the normal operations of the company are not expected to be adversely impacted [1][7] Auction Details - The auction took place from June 9 to June 10, 2025, with a total of 199,199,990 shares available for bidding [5] - The successful bidders included individuals such as Wang Mei'er, Chen Zhiwenlong, and Zhang Shouchun, while some shares remained unsold due to lack of bids [1][2] - The total number of shares auctioned by Shanghai Yueye has reached 316,983,419, which is 14.64% of the current total share capital of the company [7] Shareholder Status - Following the auction, if all successfully auctioned shares are transferred, Shanghai Yueye's holdings will decrease to 97,154,647 shares, representing 4.49% of the total share capital [7] - Shanghai Yueye will no longer be classified as a shareholder holding more than 5% of the company's shares, prompting the company to ensure compliance with information disclosure obligations [7][8] Future Considerations - The auction process involves further steps such as payment of auction proceeds and share transfer registration, which carry some uncertainties [8] - The company will continue to monitor the auction's progress and fulfill its information disclosure responsibilities [1][8]

证券代码：000813 证券简称：德展健康 公告编号：2025-043 德展大健康股份有限公司 关于持股 5%以上股东所持公司股份第六次拍卖的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次拍卖是依据上海市第三中级人民法院（以下简称"上海市三中院"） 裁定确认的《清算方案》执行，本次公开拍卖股份为上海岳野股权投资管理合 伙企业（有限合伙）（以下简称"上海岳野"）持有的德展大健康股份有限公 司（以下简称"公司"）199,199,990 股无限售流通股（其所持公司股份总数 为 323,800,000 股，其中 124,600,010 股已被拍卖但尚未过户），占其所持公 司股份的 61.52%，占公司总股本的比例为 9.20%，占剔除公司回购专用账户股 份数量后的公司总股本比例为 9.39% 1。 2、上海岳野不是公司控股股东或实际控制人，其所持有的公司股份被 拍卖不会导致公司控制权发生变化，不会对公司的正常生产经营产生不利 影响。 3、本次拍卖的 199,199,990 股股份中的 102,045,343 股股份被竞拍成 功，竞买人为 ...

证券代码：000813 证券简称：德展健康 公告编号：2025-041 德展大健康股份有限公司 关于回购公司股份比例达到 2%的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 德展大健康股份有限公司（以下简称"公司"）分别于 2024 年 7 月 1 日及 2024 年 7 月 18 日召开了第八届董事会第二十七次会议和 2024 年第一次临时股 东大会，审议并通过了《关于回购公司股份方案的议案》。基于对公司所属行业 前景的认可、对公司未来发展的信心及公司价值的判断，为进一步增强投资者信 心，稳定投资者预期，维护广大投资者的利益，公司计划自股东大会审议通过之 日起 12 个月内使用不低于人民币 2 亿元，不超过人民币 3 亿元的自有资金，通 过集中竞价交易方式以不超过人民币 3.59 元/股的价格回购股份。本次回购的股 份将全部用于注销减少公司注册资本。具体内容详见公司于 2024 年 7 月 19 日在 《证券时报》《证券日报》《上海证券报》《中国证券报》和巨潮资讯网 （www.cninfo.com.cn）披露的《回购报告书》（公告编号：2024- ...

Core Viewpoint - The company, Dezhan Health (000813), has announced a share repurchase plan to enhance shareholder value and reduce registered capital [1] Group 1: Share Repurchase Plan - The board and shareholders' meetings are scheduled for July 1 and July 18, 2024, to approve the share repurchase plan [1] - The company plans to use between 200 million and 300 million yuan of its own funds and bank loans for the repurchase, with a maximum buyback price of 3.59 yuan per share [1] - The repurchased shares will be used for cancellation to reduce the company's registered capital [1] Group 2: Repurchase Progress - As of May 26, 2025, the company has repurchased a total of 43.1994 million shares, accounting for 2.00% of the total share capital [1] - The highest transaction price during the repurchase was 3.29 yuan per share, while the lowest was 2.39 yuan per share [1] - The total amount spent on the repurchase reached 119 million yuan, excluding transaction fees [1]

Core Viewpoint - The announcement details the new judicial freezing of shares held by a major shareholder of Dezheng Health, which may impact investor sentiment but is not expected to affect the company's daily operations [2][4]. Group 1: Shareholder Information - The major shareholder, Meilin Holdings Group, holds 186,038,682 shares, representing 8.59% of the total share capital, with 100% of these shares currently frozen [2][3]. - The total number of shares under judicial freezing and pending freezing amounts to 257,887,347 shares, exceeding the total shares held by Meilin Holdings [2][4]. Group 2: Impact on the Company - Meilin Holdings is not the controlling shareholder or actual controller of the company, and the new share freezing is not expected to impact the company's management or operations [4][19]. - The company will continue to monitor the situation and fulfill its information disclosure obligations as required [4][19]. Group 3: Auction Information - A sixth auction of shares held by another major shareholder, Shanghai Yueye Equity Investment Management Partnership, is scheduled, involving 199,199,990 shares, which is 9.20% of the total share capital [10][11]. - The auction is part of a liquidation plan confirmed by the Shanghai Third Intermediate People's Court, and the auction results are uncertain due to the ongoing public notice phase [10][19].

德展大健康股份有限公司 关于持股 5%以上股东所持公司股份 第六次拍卖的提示性公告 证券代码：000813 证券简称：德展健康 公告编号：2025-040 股东上海岳野股权投资管理合伙企业（有限合伙）保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、本次拍卖是依据上海市第三中级人民法院（以下简称"上海市三中院"） 裁定确认的《清算方案》执行，本次公开拍卖股份为上海岳野股权投资管理合伙 企业（有限合伙）（以下简称"上海岳野"）持有的德展大健康股份有限公司（以 下简称"公司""上市公司"）199,199,990 股无限售流通股（其所持公司股份 总数为 323,800,000 股，其中 124,600,010 股已被拍卖但尚未过户），占其所持 公司股份的 61.52%，占公司总股本的比例为 9.20%，占剔除公司回购专用账户股 份数量后的公司总股本比例为 9.34%1。 10 时止（延时除外）在京东司法拍卖平台（https://paimai.jd.com/308594791） 对上述 199,199 ...